Consultative Hemostasis and Thrombosis. Edition No. 4

  • ID: 4483048
  • Book
  • 850 Pages
  • Elsevier Health Science
1 of 4
With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis. This trusted resource by Drs. Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, Michael B. Streiff, and David A. Garcia is designed for rapid reference and critical decision making at the point of care.
Note: Product cover images may vary from those shown
2 of 4
Kitchens: CONSULTATIVE HEMOSTASIS & THROMBOSIS

TOC

PART 1: Hemorrhagic Processes

1. Consultative Process

2. An Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing

3. Hemophilia A and B

4. Less Common Congenital Disorders of Hemostasis

5. Acquired Coagulation Disorders Due to Inhibitors

6. von Willebrand Disease

7. General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors

8. Primary Immune Thrombocytopenia

9. Congenital and Acquired Disorders of Platelet Function and Number

10. Purpura and Other Hematovascular Disorders

11. HHT

12. Disseminated Intravascular Coagulation

13. The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

PART 2: Thrombotic Processes

14. Thrombophilia: Clinical and Laboratory Assessment and Management

15. Pediatric Aspects of Thrombophilia

16. Deep Vein Thrombosis, Pulmonary Embolism and Primary Pulmonary Hypertension

17. Venous Thromboses at Unusual Sites

18. The Post Thrombotic Syndrome

19. Thrombocytosis: Essential Thrombocytemia and Reactive Causes

20. Antiphospholipid Syndrome

21. Antiplatelet Treatment in Cardiovascular Medicine

22. Non-Arteriosclerotic Arterial Occlusive Disease

23. Thrombosis and Cancer

24. Thrombotic Thrombocytopenic Purpura

25. Hemostatic Disorders of Complement Activation (PNH and aHUS) - New Chapter

26. Heparin-Induced Thrombocytopenia

PART 3: Therapeutic Agents

27. Antithrombotic Agents

28. Blood Component and Pharmacological Agents

29. Therapeutic Apheresis â?" Applications for Hemorrhagic & Thrombotic Disorders

30. Vena Caval Filters

PART 4: Issues Specific to Women

31. Thrombotic Risk of Contraceptives and other Hormnal Therapies

32. Bleeding and the Management of Hemorrhagic Disorders in Pregnancy

33. Thrombophilia in Pregnancy

PART 5: Special Issues

34. Surgery and Hemostasis

35. Anticoagulation in the Perioperative Period

36. Understanding and Managing the Coagulopathy of Liver Disease

37. Outpatient Anticoagulant Therapy38. Hematologic Interventions for Acute Central Nervous System Disease

39. Pending: Atrial Septal Abnormalties and Cryptogenic Stroke

40. Hemorrhage Control and Thrombosis Following Severe Injury

41. Hemostatic Aspects of Sickle Cell Disease
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Kitchens, Craig S. Professor Emeritus, Medicine, University of Florida; Consultant, Malcom Randall Veterans Administration Medical Center, Gainsville Florida; Consultant, Florida Cancer Specialists and Research Institute, Fort Myers, Florida.

Konkle, Barbara A Director, Clinical and Translational Research, Puget Sound Blood Center; Professor of Medicine/Hematology, University of Washington, Seattle, Washington.

Kessler, Craig M. Professor of Medicine and Pathology, Georgetown University School of Medicine; Director, Coagulation Laboratory, Lombardi Comprehensive Cancer Center, Washington, DC.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll